Languages Available
 
C

PT. Phapros Tbk [PEHA]   IDR 2.520  -20 (-0,79%)


Loading...
PEHA IDR 2.520  -20 (-0,79%)
Last Update 23 January 2019 12:54 PM
Open
IDR 2.540
Prev Close
IDR 2.540
Offer
IDR 2.530
Bid
IDR 2.510
Day Low
IDR 2.520
Day High
IDR 2.540
Volume
731 Lots (73.100 Shares)
Transaction Value (IDR)
184,56 M
Frequency
23 (Times)
EPS (IDR)
162,15
PE Ratio (ttm)
15,54 Times
Market Cap. (IDR)
2.116.800,00 M
Market Cap. Rank in Industry
#7 of 12 Companies in Pharmaceuticals
Market Cap. Rank in All Companies
#284 of 649 Companies
F
Net Foreign

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
O
Overview


PT. Phapros Tbk (PEHA) is engaged in medicines, medicinal raw materials, medical tools & services. The Company commenced its commercial operations in 1957. The company is a pharmaceutical company which is a subsidiary of PT. Rajawali Nusantara Indonesia (RNI).

I
IPO
IPO Date26 December 2018
Offering Shares287.375.690
Company Listing552.374.310
Total List Shares840.000.000
Percentage34,21 %
Offering PriceRp 1.198
Fund RaisedRp 1.006.320.000.000
Securities Administration BureauPT. BSR Indonesia
Lead UnderwriterPT. Bahana Sekuritas
Listing BoardDevelopment
No IPO bonds found
No IPO rights issue found
D
Dividend
No dividend found
G
Management
Commissioners
-
President Commissioner
Johanes Nanang Marjianto
Independent Commissioner
Independent Commissioner
Directors
-
President Director
Director
Director
Director
Independent Director
Fransetya Hasudungan Hutabarat
Graph goes here...
S
Shareholders
No. Shareholder Name Number of Shares Total Paidup Capital Percentage
1. PT. RNI (Persero) 476.901.860 IDR 47.690.186.000 56,77 %
2. Public (each below 5%) 287.375.690 IDR 28.737.569.000 34,21 %
3. Masrizal Achmad Syarief 75.722.450 IDR 7.572.245.000 9,01 %
S
News Update
26 December 2018 12:10 PM Phapros officially listed as last issuer in 2018
S
Financial
Full financial and operational data available to our premium users. Please check our premium data introduction page to learn more about our tools.
No financial statement found
IPO STOCK